From: Genetic polymorphism of the OPG gene associated with breast cancer
Clinical parameters | Breast cancer patients (n=307) | Healthy controls (n=396) |
---|---|---|
Age (median) in years k | 56 (22-91) | 45 (18-88) |
Menopausal status | n=287 | Â |
Premenopausal | 88 (31%) | Â |
Postmenopausal | 179 (62%) | Â |
Perimenopausal | 20 (7%) | Â |
Unknown | 20 | Â |
Tumor growth | n=303 | Â |
Invasive | 275 (91%) | Â |
Non-invasive | 28 (9%) | Â |
Unknown | 4 | Â |
Localization | n=306 | Â |
Right | 123 (40%) | Â |
Left | 173 (57%) | Â |
Bilateral | 10 (3%) | Â |
Unknown | 1 | Â |
Type a, b | n=255 | Â |
Ductal | 189 (74%) | Â |
Lobular | 34 (13%) | Â |
Other types | 32 (13%) | Â |
Unknown | 21 | Â |
Tumor size (T) a, b, c | n=229 | Â |
T1 (< 2 cm) | 142 (62%) |  |
T2 (>/= 2 cm – 5 cm) | 76 (33%) |  |
T3 (</= 5 cm) | 6 (3%) |  |
T4 (infiltration of the chest | 5 (2%) | Â |
wall/skin) | Â | Â |
Unknown | 24 | Â |
Nodal status (N) b, c | n=250 | Â |
N+ | 75 (30%) | Â |
N- | 175 (70%) | Â |
Unknown | 36 | Â |
Distant metastases (M) | n=292 | Â |
M+ | 16 (5%) | Â |
osseous | 10 (3%) | Â |
M- | 276 (95%) | Â |
Unknown | 15 | Â |
Tumor grading (G) | n=245 | Â |
G1 | 16 (6%) | Â |
G2 | 161 (63%) | Â |
G3 | 78 (31%) | Â |
Unknown | 49 | Â |
Estrogen receptor (ER) d | n=275 | Â |
ER+ | 224 (81%) | Â |
ER- | 51 (19%) | Â |
Unknown | 32 | Â |
Progesterone receptor (PR) b, d | n=274 | Â |
PR+ | 193 (70%) | Â |
PR- | 81 (30%) | Â |
Unknown | 32 | Â |
Her-2 a, b, e | n=208 | Â |
Her2+ | 42 (20%) | Â |
Her2- | 166 (80%) | Â |
Unknown | 67 | Â |
Ki67 a, b, f | n=187 | Â |
Ki67+ | 84 (45%) | Â |
Ki67- | 103 (55%) | Â |
Unknown | 88 | Â |
CEA f | n=107 | Â |
CEA+ | 26 (24%) | Â |
CEA- | 81 (76%) | Â |
Unknown | 200 | Â |
CA15-3 h | n=215 | Â |
CA15-3+ | 81 (38%) | Â |
CA15-3- | 134 (62%) | Â |
Unknown | 92 | Â |
Body mass index (BMI) m | n=219 | Â |
BMI < 28 | 150 (68%) | Â |
BMI >/= 28 | 69 (32%) | Â |
Unknown | 88 | Â |
Subgroup a, i | n=249 | Â |
Triple negative | 22 (9%) | Â |
Non triple negative | 227 (91%) | Â |
Unknown | 30 | Â |
Subgroup a, j | n=262 | Â |
Risk group | 18 (7%) | Â |
Non risk group | 244 (93%) | Â |
Unknown | 15 | Â |